Anticorps Polyclonal de lapin anti-PPP4C
PPP4C Polyclonal Antibody for WB, IP, IF, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 10262-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HEK-293, cellules Jurkat, tissu rénal de souris |
Résultats positifs en IP | tissu rénal de souris |
Résultats positifs en IF/ICC | cellules HEK-293 |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 3 publications below |
IF | See 1 publications below |
IP | See 3 publications below |
Informations sur le produit
10262-1-AP cible PPP4C dans les applications de WB, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | PPP4C Protéine recombinante Ag0356 |
Nom complet | protein phosphatase 4 (formerly X), catalytic subunit |
Masse moléculaire calculée | 35 kDa |
Poids moléculaire observé | 35 kDa |
Numéro d’acquisition GenBank | BC001416 |
Symbole du gène | PPP4C |
Identification du gène (NCBI) | 5531 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
The phosphorylation and dephosphorylation of proteins on serine and threonine residues is an essential means of regulating a broad range of cellular functions. The serine/threonine protein phosphatases (PP) are intimately involved in this process. Serine/threonine protein phosphatase X (PPX; also called protein phosphatase 4 (PP4)) are specifically associated with nuclear factor-kappa B (NF-kappa B) p50, c-Rel, and RelA, which are pleiotropic transcription factors that play central roles in the immune and inflammatory responses, as well as apoptosis. Overexpression of PPX stimulated the DNA-binding activity of c-Rel and activated NF-kappa B-mediated transcription. Although the mechanism by which PPX activates Rel/NF-kappa B-mediated transcription is unclear, PPX appeared to act on Rel/NF-kappa B proteins directly through augmentation of c-Rel activity. It is also possible that PPX may dephosphorylate and subsequently activate other c-Rel-associated transcription factors or other kinases regulating I kappaB (e.g. I kappa B kinases or MEKK1). These data suggest that PPX is an activator, but not an inhibitor, of c-Rel/NF-kappa B, which is in contrast to other protein phosphatases.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for PPP4C antibody 10262-1-AP | Download protocol |
IF protocol for PPP4C antibody 10262-1-AP | Download protocol |
IP protocol for PPP4C antibody 10262-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Genes Dev Protein phosphatase 4 controls circadian clock dynamics by modulating CLOCK/BMAL1 activity. | ||
Cell Rep Kin17 regulates proper cortical localization of Miranda in Drosophila neuroblasts by regulating Flfl expression
| ||
Front Cardiovasc Med Macrophages-Related Genes Biomarkers in the Deterioration of Atherosclerosis. | ||
FEBS Lett Protein phosphatase 4 negatively regulates LPS cascade by inhibiting ubiquitination of TRAF6. | ||
Cell Death Differ AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c mediated IKK dephosphorylation in an autophagy-independent manner |